Events

Retiro De Equipo (Recall) de Reagents, control materials and calibrators for in vitro detection of prostate-specific antigen (PSA) on AxSYM and ARCHITECT i immunochemical analyzers

Según Federal Service for Surveillance in Healthcare, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Russian Federation que fue producido por Abbott Island Diagnostic Division.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    03И-1401/18, ФСЗ 2011/09339
  • Fecha
    2018-06-04
  • Fecha de publicación del evento
    2018-06-04
  • País del evento
    Russian Federation
  • Fuente del evento
    FSSH
  • URL de la fuente del evento
    http://www.roszdravnadzor.ru/services/unreg
  • Notas / Alertas
    Russian data is current through January 2019. All of the data comes from the Federal Service for Surveillance in Healthcare, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Russia.
  • Notas adicionales en la data
    Manufacturer Recall

Device

Reagents, control materials and calibrators for in vitro detection of prostate-specific antigen (...

Manufacturer

Abbott Island Diagnostic Division
  • Empresa matriz del fabricante (2017)
    Abbott Laboratories
  • Comentario del fabricante
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    FSSH